论文部分内容阅读
本文对49例原发性肝癌(PHC)病人,进行了血清IgG、IgA、IgM、C_1q、C_3、C_4、B因子的测定。观察PHC的免疫球蛋白和补体份量的变化,现将结果报告如下。材料与方法一、病例选择系本院1991年住院的PHC(按全国肝癌协作组拟订的通用诊断标准)49例,其中男45例,女4例,年龄36～73岁,平均50.2岁。选择健康人57例对照观察。二、方法采用单向免疫扩散法。IgG、IgA、IgM、C_3、C_4免疫板为总参管理局卫生处中心实验室供应,抗C_1q、B因血清和IgG、IgA、IgM、C_1q、C_3、C_4、B因子参考血清购自上海生物制品
In this paper, serum IgG, IgA, IgM, C_1q, C_3, C_4, and B factors were measured in 49 patients with primary liver cancer (PHC). Observe changes in the immunoglobulin and complement levels of PHC and report the results as follows. Materials and Methods 1. The case selection was 49 cases of PHC hospitalized in 1991 (according to the universal diagnostic criteria developed by the National Hepatoma Collaboration Group), including 45 males and 4 females, aged 36-73 years, with an average of 50.2 years. Choose healthy people in 57 cases to observe. Second, the method uses a one-way immunodiffusion method. The IgG, IgA, IgM, C_3, C_4 immunoplates were supplied by the Central Laboratory of the General Administration of Health, and anti-C_1q and B were purchased from Shanghai Bio-products for serum and IgG, IgA, IgM, C_1q, C_3, C_4, and B factor reference serums.